Repeat: The levels of tumour DNA tell us how the cancer is responding to treatment.’ Professor Peter Johnson, Cancer Research UK’s chief clinician, said: ‘These results hold the promise of a system that could allow us to modify someone’s treatment as their cancer changes, and they suggest an exciting way to quickly get hold of the personal details of a cancer, to target it for the most effective therapy.’ A breakthrough drug for women with an aggressive form of breast cancer could prevent their condition worsening for an extra six months.
The levels of tumour DNA tell us how the cancer is responding to treatment.’ Professor Peter Johnson, Cancer Research UK’s chief clinician, said: ‘These results hold the promise of a system that could allow us to modify someone’s treatment as their cancer changes, and they suggest an exciting way to quickly get hold of the personal details of a cancer, to target it for the most effective therapy.’ A breakthrough drug for women with an aggressive form of breast cancer could prevent their condition worsening for an extra six months.